Chun-Ying Yeh-Huang
Director/Board Member bij TOT BIOPHARM INTERNATIONAL COMPANY LIMITED
Vermogen: 2 M $ op 31-03-2024
Profiel
Chun-Ying Yeh-Huang is currently the Vice Chairman at TOT BIOPHARM International Co. Ltd.
since 2020 and the Director at Tot Biopharm Co. Ltd.
since 2023.
Previously, Ms. Yeh-Huang worked at TTY Biopharm Co. Ltd.
as the Executive VP-Oncology Science Business Development from 2011 to 2015.
Ms. Yeh-Huang completed their undergraduate degree at Taipei Medical University in 1982.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-01-2023 | 8 363 083 ( 1.08% ) | 2 M $ | 31-03-2024 |
Actieve functies van Chun-Ying Yeh-Huang
| Bedrijven | Functie | Begin |
|---|---|---|
| TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Director/Board Member | 19-01-2016 |
Tot Biopharm Co. Ltd.
 Tot Biopharm Co. Ltd. Pharmaceuticals: MajorHealth Technology Tot Biopharm Co. Ltd. engages in research and development, manufacturing and sales of new drugs. The company was founded on July 5, 2010 and is headquartered in Suzhou, China. | Director/Board Member | - |
Eerdere bekende functies van Chun-Ying Yeh-Huang
| Bedrijven | Functie | Einde |
|---|---|---|
| TTY BIOPHARM COMPANY LIMITED | Corporate Officer/Principal | 01-12-2015 |
Opleiding van Chun-Ying Yeh-Huang
| Taipei Medical University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| TTY BIOPHARM COMPANY LIMITED | Health Technology |
| TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Tot Biopharm Co. Ltd.
Tot Biopharm Co. Ltd. Pharmaceuticals: MajorHealth Technology Tot Biopharm Co. Ltd. engages in research and development, manufacturing and sales of new drugs. The company was founded on July 5, 2010 and is headquartered in Suzhou, China. | Health Technology |
